Search by Drug Name or NDC
NDC 45802-0436-94 TAZAROTENE 0.5 mg/g Details
TAZAROTENE 0.5 mg/g
TAZAROTENE is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is TAZAROTENE.
MedlinePlus Drug Summary
Tazarotene (Tazorac, Fabior) is used to treat acne. Tazarotene (Tazorac) is also used to treat psoriasis (a skin disease in which red, scaly patches form on some areas of the body). Tazarotene (Avage) is used to reduce facial wrinkling and discoloration in patients who are also using other skin care and sunlight avoidance programs. Tazarotene is in a class of medications called retinoids. It works to treat acne and psoriasis by slowing skin cell overgrowth and decreasing skin cell inflammation, which can lead to acne or psoriasis. It works to reduce facial wrinkles and discoloration by causing an increase in the thickness of the outer skin layers.
Related Packages: 45802-0436-94Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Tazarotene Topical
Product Information
| NDC | 45802-0436 |
|---|---|
| Product ID | 45802-436_cb71f814-6c05-474c-8dd0-27f5398871ff |
| Associated GPIs | |
| GCN Sequence Number | 031600 |
| GCN Sequence Number Description | tazarotene GEL (GRAM) 0.05 % TOPICAL |
| HIC3 | L5F |
| HIC3 Description | ANTIPSORIATICS AGENTS |
| GCN | 29221 |
| HICL Sequence Number | 013315 |
| HICL Sequence Number Description | TAZAROTENE |
| Brand/Generic | Generic |
| Proprietary Name | TAZAROTENE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | tazarotene |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | TOPICAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/g |
| Substance Name | TAZAROTENE |
| Labeler Name | Padagis Israel Pharmaceuticals Ltd |
| Pharmaceutical Class | Retinoid [EPC], Retinoids [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213079 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 45802-0436-94 (45802043694)
| NDC Package Code | 45802-436-94 |
|---|---|
| Billing NDC | 45802043694 |
| Package | 1 TUBE in 1 CARTON (45802-436-94) / 30 g in 1 TUBE |
| Marketing Start Date | 2023-06-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 8.13878 |
| Pricing Unit | GM |
| Effective Date | 2023-09-20 |
| NDC Description | TAZAROTENE 0.05% GEL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |